Furthermore, by colony formation assay, transient transfection assay and western blot, we found that CDKN1A was highly expressed in TMZ-resistant glioma cells and involved in AKT-mediated TMZ resistance of glioma cells. Here, CDKN1A is linked to central nervous system cancer.